Clinical Trials Directory

Trials / Completed

CompletedNCT05020756

Study in Children Who Have Switched to Isosource Junior Mix Formula

A Retrospective Study in Children Who Have Switched to Isosource Junior Mix Formula (RICIMIX Study)

Status
Completed
Phase
Study type
Observational
Enrollment
43 (actual)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
All
Age
12 Months – 14 Years
Healthy volunteers
Not accepted

Summary

A Retrospective study In Children who have switched to Isosource Junior Mix formula (RICIMIX study) will review paediatric children \> 12 months of age who require Isosource Junior Mix as an enteral tube feeding formula and have consumed the formula for at least 1 month. The purpose of this study is to understand If there has been an improvement in outcomes/ experiences * The current usage of ISJMIX formula in children who require blended diets * Improved feeding intolerances * Improved patient outcomes/ experiences

Detailed description

Retrospective data will be collected using questionnaire by the dietitians at the nutrition and dietetic department. All completed questionnaires will be sent back to Nestle Health Science/ CRO company. The primary objectives: The following measures will be collected retrospectively after 1 month use of ISJMIX * Feeding tolerance \[no change, tolerance improved, tolerance worsened\]: gastric residuals, gagging/retching, vomiting, abdominal distention/ gas, stool consistency issues (too hard, too loose) * Volume of formula consumed in a day The secondary objective is to collect restropective data on: * Any improved patient outcomes noted * Calculate the potential cost savings made when using ISJMIX to help manage the feeding intolerances * Calculate the potential costs benefit of using ISJMIX over other standard formulas

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTIsosource Junior MixSingle arm study, collecting data on those who have been on Isosourcr Junior mix tube feed formula for 30 days

Timeline

Start date
2021-03-26
Primary completion
2021-03-26
Completion
2021-08-02
First posted
2021-08-25
Last updated
2024-11-06

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05020756. Inclusion in this directory is not an endorsement.